Skip to main content

Day: December 9, 2024

VivoPower’s Caret Digital secures asset backed financing facility for up to 1,000 Antminer L9s to accelerate DOGE coin mining revenues and free cashflows

Asset backed financing facility is for Caret LLC (trading as Caret Digital) and is non-dilutive to VivoPower shareholders At current DOGE coin prices, 1,000 Antminer L9s can generate up to US$25m revenues per annum 1,000 Antminer L9s represents approximately 17,000 GH (GigaHash) / s of hash power London, Dec. 09, 2024 (GLOBE NEWSWIRE) — VivoPower International PLC (NASDAQ: VVPR) (the “Company” or “VivoPower”) announced today that its wholly owned subsidiary, Caret LLC (trading as “Caret Digital”), has secured an initial asset backed financing facility to fund the purchase of up to 1,000 Antminer L9s. As a result of securing this facility, the fleet of 1,000 Antminer L9s is expected to be delivered to hosting facilities from December 2024. It will have a total hash rate of approximately 17,000 GH/s. From this initial fleet, Caret...

Continue reading

Sonnet BioTherapeutics Announces $3.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

PRINCETON, NJ, Dec. 09, 2024 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ:SONN), a clinical-stage company developing targeted immunotherapeutic drugs, announced today that it has entered into a definitive agreement with institutional investors for the purchase and sale of an aggregate of 1,085,325 shares of its common stock (or common stock equivalents in lieu thereof) (the “Registered Direct Shares”) and warrants to purchase up to an aggregate of 1,085,325 shares of common stock (the “Registered Direct Warrants”), in a registered direct offering. Each share of common stock (or pre-funded warrant in lieu thereof) is being sold in the registered direct offering together with one common warrant at a combined offering price of $2.23, priced at-the-market under...

Continue reading

Vow ASA: Resolution to increase the share capital in connection with settlement of underwriting commission

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT. Oslo, 9 December 2024: Reference is made to the stock exchange announcement published by Vow ASA (the “Company“) on 19 November 2024 regarding the approval by the extraordinary general meeting of the Company of a fully underwritten rights issue of 166,666,666 new shares in the Company (the “Offer Shares“), at a subscription price of NOK 1.50 per share...

Continue reading

Progressive Announces Dividend Information And 2025 Annual Meeting Record Date

MAYFIELD VILLAGE, OHIO, Dec. 09, 2024 (GLOBE NEWSWIRE) — On December 6, 2024, the Board of Directors of The Progressive Corporation (NYSE:PGR) declared an annual common share dividend, in the amount of $4.50 per share, and a quarterly common share dividend, in the amount of $0.10 per share. Both the annual and quarterly dividends are payable January 16, 2025, to shareholders of record at the close of business on January 9, 2025. The annual dividend amount for 2024 was determined by the Board based on our capital position, existing capital resources, and expected current and future capital needs. The Board is expected to continue to declare quarterly dividends for 2025. The Board also set the close of business on March 14, 2025, as the record date for the determination of shareholders entitled to notice of, and to vote at, Progressive’s...

Continue reading

Espey Declares Regular Quarterly Dividend of $0.25 Per Share; Appoints New Corporate Secretary

SARATOGA SPRINGS, N.Y., Dec. 09, 2024 (GLOBE NEWSWIRE) — The Board of Directors of Espey Mfg. & Electronics Corp. (NYSE AMERICAN: ESP) has declared a regular quarterly dividend of $0.25 per share. The dividend will be payable on December 27, 2024 to all shareholders of record on December 20, 2024. Furthermore, the Board of Directors appointed Ms. Jennifer Pickering to the position of Corporate Secretary. Jennifer joined the Company as Chief Human Resources Officer in April 2024 and previously served as Assistant Corporate Secretary since June 2024. This appointment comes after the retirement of Ms. Peggy A. Murphy, effective December 6, 2024. Ms. Murphy was employed by the Company since October 1978 and held the position of Corporate Secretary since December 1998. Espey’s primary business is the development, design,...

Continue reading

EUROAPI moves into a new chapter with new Governance and Leadership 

  Press Release   Emmanuel Blin appointed Independent Chair of the Board of DirectorsDavid Seignolle appointed Chief Executive OfficerFull-year 2024 guidance maintained Paris – December 9, 2024 – With FOCUS-27 strategic plan foundations established and its financing secured, EUROAPI moves into a new chapter. The company’s Board of Directors has accepted today the resignation of Viviane Monges as Director and Chair of the Board and Ludwig de Mot as Chief Executive Officer. Consequently, upon the recommendation of the Nominations and Compensation Committee, the Board has appointed Emmanuel Blin as Chair of the Board and David Seignolle as Chief Executive Officer, effective immediately. In response to the new governance, Elizabeth Bastoni stepped down as Independent Lead Director; she remains Chair of the Nominations and Compensation...

Continue reading

Press Release: ASH: Sarclisa combinations demonstrated significant benefits in newly diagnosed multiple myeloma patients

ASH: Sarclisa combinations demonstrated significant benefits in newly diagnosed multiple myeloma patientsNew analysis from the IMROZ phase 3 study of Sarclisa-VRd demonstrated higher and sustained MRD negativity rates in transplant-ineligible NDMM patients versus VRd alone New detailed results from the GMMG-HD7 phase 3 study of Sarclisa-RVd induction therapy resulted in a significant and clinically meaningful PFS benefit with deeper MRD negativity in transplant-eligible NDMM patients Results support the benefit of Sarclisa-based combinations to patients in the front-line setting and the ongoing use of MRD negativity as a potential surrogate endpoint for PFS in MM researchParis, December 9, 2024. New data from three oral presentations, which demonstrated significant clinical benefit with Sarclisa-based quadruplets in newly diagnosed...

Continue reading

Affimed Reports Promising Phase 1 Efficacy and Safety Data for AFM28 in Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

AFM28, a bispecific, tetravalent innate cell engager (ICE®) targeting CD123 and CD16A, achieved a 40% composite complete remission rate (CRcR) at the highest dose level (300 mg) in heavily pretreated R/R AML patients AFM28 demonstrates a favorable safety profile: Grade 1 and 2 Infusion related reactions (IRRs) were the main related side effect, occurring in 45% of patients; no signs of neurotoxicity or immune-related side effects were observed Based on the good safety profile and likely dose-effect relationship, the evaluation of higher dose levels is plannedMANNHEIM, Germany, Dec. 09, 2024 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced the oral presentation of data on...

Continue reading

Fluke Networks Adds Advanced Wi-Fi 6E Troubleshooting Capabilities to LinkIQ

New LinkIQ Duo combines cable, Wi-Fi, and network testing in one easy-to-use solution Everett, Washington, Dec. 09, 2024 (GLOBE NEWSWIRE) — Fluke Networks today announced the availability of the LinkIQ™ Duo Cable+WiFi+Network Tester, which combines the company’s trusted cabling qualification with Wi-Fi 6E network testing and analysis into a single, simple-to-use solution, eliminating the need for technicians to use multiple tools. The introduction of the LinkIQ Duo advanced Wi-Fi testing capabilities is well-timed to meet the unique challenges and requirements technicians face with the rapid adoption of Wi-Fi 6E. According to industry reports, approximately 5.2 million Wi-Fi 6E access points are expected to be shipped in 2024 – up from 1.5 million in 2022 – representing a significant increase as businesses seek to upgrade...

Continue reading

Stingray Successfully Completes Long Term Refinancing with a $500M Revolving Credit Facility, Enhancing Financial Flexibility 

Increases credit facility by $80M to $500M and extends term to December 2028  Ability to seek incremental commitments up to an additional $100M, subject to predetermined conditions Provides increased operational and M&A flexibilityMONTREAL, Dec. 09, 2024 (GLOBE NEWSWIRE) — Stingray Group Inc. (TSX: RAY.A; RAY.B) (“Stingray”), an industry leader in music and video content distribution, business services, and advertising solutions, today announced that it has successfully completed the increase and extension of its existing credit facility, providing additional liquidity for operations and M&A activities. The refinancing consists of a $500 million revolving credit facility maturing in December 2028. “We are delighted to have the ongoing support from our current banking syndicate and partners as we explore growth...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.